Semaglutide · Delaware
Semaglutide Online in Delaware
Weekly injection or daily tablet: semaglutide care for Delaware residents, managed online by licensed physicians.
As low as $139.00
Is semaglutide available in Delaware?
Yes. YOURx Health offers semaglutide to eligible adults in Delaware through telehealth. We serve every US state except Mississippi, and no clinic visit is needed.
Every patient here is matched with a provider licensed in Delaware. Depending on your history, that may mean an online health profile, a video consultation or both. When labs are required, you can use a local lab requisition or an at-home test kit.
If you are prescribed semaglutide, it ships directly to your door in Delaware in discreet packaging. Standard shipping is free of charge to every address we serve. Expect about 1–6 days from processing to delivery: 0–1 days to process plus 1–5 days in transit. These delivery estimates are not guaranteed.
Delaware has 1,059,952 residents (Census Bureau estimate, 2025), and telehealth reaches all of them the same way. Neighboring Maryland, Pennsylvania and New Jersey are served the same way.
What is semaglutide?
Semaglutide belongs to a class of medicines called GLP-1 receptor agonists. It imitates GLP-1, a hormone involved in appetite and blood-sugar regulation. In weight care, it is prescribed alongside nutrition and activity changes, not instead of them.
You may know semaglutide from the brand names Ozempic® and Wegovy®. Wegovy® is FDA-approved for weight loss, while Ozempic® is FDA-approved for type 2 diabetes and may be prescribed off-label for weight loss at a provider's discretion. Compounded semaglutide is another option your provider may consider when appropriate.
Most protocols begin low and rise in stages, which helps limit side effects. Our Health Hub explains the standard schedule week by week and the dosing mistakes that commonly stall progress.
It is generally prescribed to adults who qualify for medical weight loss on BMI or metabolic labs, often after diet and exercise alone stopped holding. A BMI of 25–29 may also be considered after further review for additional weight-related medical issues. Your provider also reviews your medications and medical history before deciding.

Forms we offer
- Semaglutide InjectionAs low as $159.00
A weekly injection protocol with vitamin B12; administration instructions come from your physician.
- Semaglutide RDT-TabletAs low as $139.00
A once-a-day tablet with food, enhanced with B-complex vitamins, for patients who would rather skip needles.
From intake to delivery in Delaware
The process is the same for every patient, wherever you are in the state.
Step 1: Health profile
Fill in your health profile online from anywhere in Delaware. It takes a few minutes, and honest answers help your provider decide safely.Step 2: Physician review
A board-certified physician licensed in Delaware reviews your information. If treatment is not right for you, they will tell you why.Step 3: Delivered to your door
Your prescription is filled by a licensed pharmacy and shipped to your door. Standard shipping is free, and most orders arrive within 1–6 days of processing.Step 4: Ongoing support
Our care team answers questions as you go, and your physician adjusts your plan when needed. Subscriptions can be paused, postponed or cancelled before your next shipment.
Delaware health snapshot
Statewide, 36.3% of Delaware adults reported obesity in 2025, above the U.S. figure of 33.5% (CDC BRFSS). Among the 47 states we serve with 2025 figures, Delaware places 14th for adult obesity.
13.4% of adults in Delaware have been told by a doctor they have diabetes, against a median of 12.2% across all states and DC. On diagnosed diabetes it ranks 9th of the 47 states we serve with 2025 data.
Obesity and type 2 diabetes are the two conditions brand-name GLP-1 medications are approved for, so these figures show how common the need is locally. Your own eligibility is decided individually.
- Adults with obesity, Delaware
- 36.3%2025; U.S.: 33.5%Source: CDC Behavioral Risk Factor Surveillance System (BRFSS), Nutrition, Physical Activity, and Obesity
- Adults with diagnosed diabetes, Delaware
- 13.4%2025; median of all states and DC: 12.2%Source: CDC Behavioral Risk Factor Surveillance System (BRFSS) Prevalence Data
Sources: CDC BRFSS (self-reported, state level) and CDC PLACES (model-based local estimates). Years and methods differ, so compare figures as context rather than as a ranking of individual health.
What semaglutide costs in Delaware
There is no regional markup for Delaware. The lowest-priced option is $139/month; the products below list their own prices.
Treatment is self-pay; we do not accept medical insurance at this time. The listed price covers your consultation, supplies, shipping and ongoing support.
What's Included
- Physician ConsultationYour intake is reviewed by a board-certified physician.
- SuppliesIncluded in the listed price.
- ShippingStandard shipping at no charge.
- Ongoing SupportCare-team help and plan adjustments as you go.
Safety and eligibility
Semaglutide is not right for everyone. Before prescribing, your provider screens for conditions that make it unsafe or need extra caution.
Severe abdominal pain that won't ease, signs of pancreatitis or an allergic reaction are reasons to stop the medication and get medical care immediately. Then loop in your prescriber.
Who should avoid it or check first
- You or a family member have had medullary thyroid carcinoma
- You have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
- You have had pancreatitis or have gallbladder disease (your physician must weigh this first)
- You are pregnant, planning a pregnancy or breastfeeding (tell your physician before starting)
Side effects to know about
- Nausea, especially early on and after dose changes
- Vomiting or diarrhea
- Constipation
- Stomach pain
- Decreased appetite
Compounded semaglutide is not FDA-approved.
YOURx Health-sourced compounded drugs are prepared by a state-licensed sterile compounding pharmacy, however compounded GLP-1 medications themselves are not FDA-approved.
Our compounded medications are prepared in the United States by licensed 503B compounding pharmacies that follow strict quality and safety standards.
Questions from Delaware patients
Do I qualify for semaglutide in Delaware?
Eligibility depends on your BMI, health history and current medications, not on where you live in Delaware. A BMI of 25–29 may also be considered after further review for additional weight-related medical issues. The final call rests with your licensed provider.
Do I need to visit a clinic in Delaware?
No. Your consultation is online with a provider licensed in Delaware. If labs are required, you can use a local lab requisition or an at-home test kit.
How is compounded semaglutide different from brand-name options?
They share an active ingredient, but compounded semaglutide is not FDA-approved. Wegovy® is FDA-approved for weight loss and Ozempic® for type 2 diabetes; a compounded version is prepared by a licensed compounding pharmacy only when a provider decides it fits.
Is a prescription guaranteed in Delaware?
No. A board-certified physician reviews your information and prescribes only if treatment is medically appropriate.
Can I pay with a credit card?
Yes, after completing the intake process, you’ll receive a secure link to add your credit card, which will be kept on file.
How are side effects handled once I start semaglutide?
Nausea is the most common early side effect of GLP-1 medications and often eases as your body adjusts. Tell your care team, because your physician can slow or adjust your protocol. Stop and seek care immediately for severe abdominal pain that won't ease or signs of an allergic reaction.
Keep exploring
Semaglutide in nearby states
Other treatments in Delaware
From the Health Hub
Telehealth in Delaware
Start your semaglutide consultation
Tell us about your health in a few minutes. If a licensed provider finds treatment appropriate, it ships free to your door.